))
Ep. 18 - Is Reefer Madness Over? Don't Count On It... (Part 1)
Manage episode 418585040 series 3546136
Content provided by Dr. Denise Foster. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Denise Foster or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The Drug Enforcement Administration, after a recommendation by the Department of Health and Human Services, has indicated it will be moving cannabis from Schedule I to Schedule III in the Controlled Substances Act. This proposed move cannabis to a lower schedule supports what science has indicated after 80 years of research - cannabis is medicine with a low potential for abuse and harm.
But in reality, rescheduling will only benefit businesses and the medical industrial complex. Why? Schedule III drugs are still under the control of the DEA and more significantly, Big Pharma. In this episode, we highlight the potential good, bad, and downright ugly repercussions of this proposed rescheduling.
26 episodes
Share
